Athira Pharma, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Athira Pharma, Inc.
CIK #0001620463
EDGAR Form CIK 2011 - 2025
10-K [0001620463]
10-Q [0001620463]
3 [0001620463]
4 [0001620463]
5 [0001620463]
8-K [0001620463]
D [0001620463]
SC 13D [0001620463]
SC 13G [0001620463]
Form 13D/13G Filer Form 13D/13G Subject Filed
Oliveira Steven Michael Athira Pharma Inc [2025-04-16]
BML Investment Partners LP Athira Pharma Inc [2024-11-07]
Baker Bros Advisors LP Athira Pharma Inc [2024-02-14]
Kayne Richard A Athira Pharma Inc [2023-04-20]
BlackRock Inc Athira Pharma Inc [2022-02-04]
Franklin Resources Inc Athira Pharma Inc [2022-02-03]
Kawas LEEN Athira Pharma Inc [2021-02-16]
Perceptive Advisors LLC Athira Pharma Inc [2021-02-08]
Venrock Healthcare Capital Partners II LP Athira Pharma Inc [2020-11-16]
RTW Investments LP Athira Pharma Inc [2020-09-28]
View All
Form 3/4/5 Subject 2011 - 2025
Athira Pharma, Inc.
Litton Mark James
San Martin Javier
Worthington Mark
Renninger Robert
Church Kevin
Edelman Joseph
Kosacz Barbara
Johnson James A
Pickering Grant
Fluke John M Jr
Panzara Michael A.
Romano Kelly A
Gengos Andrew
Lenington Rachel
Moebius Hans
Perceptive Advisors LLC
Perceptive Life Sciences Master Fund Ltd
Mileson Glenna
Yamada Tadataka
Kawas LEEN
RTW Investments LP
Wong Roderick
Terms | Privacy | Guide
tony@aum13f.com